首页> 外国专利> A double-stranded oligonucleotide comprising CTGF specific sequence and a composition for treating and preventing fibrosis related diseases and respiratory related diseases

A double-stranded oligonucleotide comprising CTGF specific sequence and a composition for treating and preventing fibrosis related diseases and respiratory related diseases

机译:包含CTGF特异性序列和用于治疗和预防纤维化相关疾病和呼吸相关疾病的组合物的双链寡核苷酸

摘要

The present invention relates to a double-stranded oligonucleotide capable of inhibiting CTGF expression with high specificity and high efficiency, a double-stranded oligonucleotide construct and nanoparticles comprising the double-stranded oligonucleotide, and a use thereof for the prevention or treatment of fibrosis or respiratory disease will be.
机译:本发明涉及一种能够抑制具有高特异性和高效率的CTGF表达的双链寡核苷酸,一种双链寡核苷酸构建体和包含双链寡核苷酸的纳米颗粒,以及用于预防或治疗纤维化或呼吸的用途疾病将是。

著录项

  • 公开/公告号KR20210063137A

    专利类型

  • 公开/公告日2021-06-01

    原文格式PDF

  • 申请/专利权人 (주)바이오니아;

    申请/专利号KR1020190151673

  • 申请日2019-11-22

  • 分类号C12N15/113;A61K31/713;A61K9/19;A61P11;A61P43;B82Y5;

  • 国家 KR

  • 入库时间 2022-08-24 19:10:36

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号